Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization
2011

The Role of MiR-155 in Lung Cancer Prognosis

Sample size: 335 publication 10 minutes Evidence: moderate

Author Information

Author(s): Donnem Tom, Eklo Katrine, Berg Thomas, Sorbye Sveinung W, Lonvik Kenneth, Al-Saad Samer, Al-Shibli Khalid, Andersen Sigve, Stenvold Helge, Bremnes Roy M, Busund Lill-Tove

Primary Institution: University Hospital of North Norway

Hypothesis

The study investigates the prognostic impact of miR-155 in non-small cell lung cancer (NSCLC) patients.

Conclusion

The prognostic impact of miR-155 depends on histological subtype and nodal status in NSCLC.

Supporting Evidence

  • High miR-155 expression was an independent negative prognostic factor in adenocarcinomas.
  • High miR-155 expression was a favorable independent prognostic factor in SCCs with lymph node metastasis.
  • MiR-155 expression did not have a significant prognostic impact in the total cohort.
  • Statistical analysis showed significant correlations with clinicopathological variables.

Takeaway

This study looks at a tiny part of our genes called miR-155 to see how it affects lung cancer. It found that miR-155 can help predict how well patients will do, depending on the type of lung cancer they have.

Methodology

Tissue samples from 335 NSCLC patients were analyzed using in situ hybridization to evaluate miR-155 expression.

Potential Biases

Potential bias in scoring due to subjective interpretation of staining intensity.

Limitations

The study is retrospective and may have selection bias due to exclusion criteria.

Participant Demographics

Median age was 67 years, with 75% male participants.

Statistical Information

P-Value

0.047

Confidence Interval

95% CI 1.01 - 3.48

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1479-5876-9-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication